Osaic Holdings
PPBT

Osaic Holdings’s Purple Biotech PPBT Stock Holding History

Osaic Holdings’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 7449
2022
Q2 		– Hold
0
– – – 7535
2022
Q1 		– Hold
0
– – – 7430
2021
Q4 		– Hold
0
– – – 7526
2021
Q1 		– Sell
-2
Closed -$2K – 6917
2020
Q4 		$2K Sell
2
-3
-60% -$2.53K ﹤0.01% 6091
2020
Q3 		$4K Hold
5
– – ﹤0.01% 5655
2020
Q2 		$11K Buy
+5
New +$4.91K ﹤0.01% 5144

Other funds holding PPBT

Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.43B AUM 25.27% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAOI
Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Osaic Holdings's PPBT Position: Q3 2022 in Review

Osaic Holdings held its Purple Biotech (PPBT) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7449.

Osaic Holdings first reported a position in PPBT in Q2 2020 and has held it in 3 quarters since. The position peaked at $11K in Q2 2020. 10 funds tracked by Wall St. Rank hold PPBT as of Q3 2022.

  • Osaic Holdings held 0 shares of Purple Biotech worth $0 as of Q3 2022.
  • Osaic Holdings left its Purple Biotech share count unchanged in Q3 2022.
  • Purple Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2022, its #7449 holding.
  • Osaic Holdings first reported a position in Purple Biotech in Q2 2020 and has held it in 3 quarters since.
  • Osaic Holdings's Purple Biotech position peaked at $11K in Q2 2020.
  • 10 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.